Results 251 to 260 of about 749,314 (382)

A review of common immunotherapy and nano immunotherapy for acute myeloid leukemia. [PDF]

Front Immunol
Wang Y, Yang X, Liu Y, Li Y.
europepmc   +1 more source

Recombinant human interleukin 6 (B‐cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1) [PDF]

, 1988
Chisato Miyaura, Kikuo Onozaki, Yukio Akiyama, Tadayoshi Taniyama, Toshio Hirano, Tadamitsu Kishimoto, Tatsuo Suda   +6 more
openalex   +1 more source

Replacing a Cereblon Ligand by a DDB1 and CUL4 Associated Factor 11 (DCAF11) Recruiter Converts a Selective Histone Deacetylase 6 PROTAC into a Pan‐Degrader

ChemMedChem, EarlyView.
This study introduced DCAF11 as an E3 ligase for PROTAC‐mediated histone deacetylase (HDAC) degradation. By replacing cereblon with DCAF11 as recruited E3 ligase, a selective HDAC6 degrader (A6) was transformed into pan‐HDAC degraders. The lead compound, 1j (FF2039), potently degraded HDACs from classes I, IIa, and IIb, showing strong antiproliferative
Felix Feller, Heiko Weber, Martina Miranda, Irina Honin, Maria Hanl, Finn K. Hansen   +5 more
wiley   +1 more source

Therapeutics of acute myeloid leukemia with central nervous system involvement. [PDF]

Clin Hematol Int
Suárez EU, Castaño-Bonilla T, Salgado R, Solán L, Lázaro-García A, Alonso-Domínguez JM.   +5 more
europepmc   +1 more source

The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q. [PDF]

, 1987
Michelle M. Le Beau, Nava Epstein, Stephen J. O’Brien, Arthur W. Nienhuis, Y C Yang, Stephen Clark, Janet D. Rowley   +6 more
openalex   +1 more source

Identifying acute myeloid leukemia subtypes based on pathway enrichment. [PDF]

Front Pharmacol
Zhong L, Luo J, Dong J, Yang X, Wang X.
europepmc   +1 more source

Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice [PDF]

, 1984
H G Bedigian, David A. Johnson, N A Jenkins, N G Copeland, Rebecca Evans   +4 more
openalex   +1 more source

Recent advances of CAR-T cells in acute myeloid leukemia. [PDF]

Ther Adv Hematol
Deng H, Wang Q, Tong X, Cui Z, Yang Y, Xiang Y.   +5 more
europepmc   +1 more source

Induction of differentiation of human and murine myeloid leukemia cells in culture by tunicamycin. [PDF]

, 1980
M Nakayasu, M Terada, Gakuzo Tamura, Takashi Sügimura   +3 more
openalex   +1 more source

The origins of the definition of complete remission in acute myeloid leukemia. [PDF]

Haematologica
Litzow MR.
europepmc   +1 more source